化学
光电流
生物传感器
异质结
级联
核酸
锁核酸
量子点
信号(编程语言)
干扰(通信)
光电子学
检出限
DNA
纳米技术
线性范围
动态范围
核酸外切酶 III
核酸外切酶
临床诊断
环介导等温扩增
基质(水族馆)
多重位移放大
降级(电信)
A-DNA
电极
作者
Na Feng,Yashu Wei,Li Xu,Yiwei Zheng,Ruxia Wei,Xuecai Tan,Jiawen Wu,Ke‐Jing Huang
出处
期刊:Analytical Chemistry
[American Chemical Society]
日期:2025-10-14
卷期号:97 (42): 23640-23649
被引量:16
标识
DOI:10.1021/acs.analchem.5c05758
摘要
The simultaneous detection of CD142 and CD41–42 mutations is critical for accurate diagnosis and precision medicine but remains challenging due to the ultralow target abundance in early stage screening. Here, we develop a dual-polarity switching photoelectrochemical biosensor based on a photocurrent polarity-switching strategy, achieving ultrasensitive dual-target detection of thalassemia genes CD142 and CD41–42 through a “cathodic-anodic-cathodic” tristate conversion. This sensor innovatively integrates a Z-scheme Bi 2 S 3 /Bi 2 WO 6 heterojunction substrate with an Ag 2 S quantum dots (anodic)/Cu 2 O (cathodic) labeling system, combined with a target-triggered cascaded nucleic acid amplification strategy: target-driven toehold-mediated strand displacement reaction with exonuclease III-assisted target cycling (TSDR-EATC) and 3D DNA walker, converting background interference into characteristic signals with self-calibration capability. Experiments demonstrate that the sensor exhibits excellent linear response in the range of 0.1 fM-0.1 μM, with detection limits of 30.9 aM (CD142) and 27.8 aM (CD41–42). Clinical sample validation shows a recovery rate of 98.0–107.9% and an RSD of ≤4.8%, and the correct rate in double-blind tests exceed 93%. This work establishes a new paradigm for polarity-switchable PEC systems by integrating heterojunction engineering with nucleic acid amplification, providing a highly reliable solution for the community screening of thalassemia.
科研通智能强力驱动
Strongly Powered by AbleSci AI